cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Phreesia Inc
4 own
1 watching
Current Price
$30.02
$0.2
(0.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,597.54M
52-Week High
52-Week High
40
52-Week Low
52-Week Low
16.78
Average Volume
Average Volume
0.94M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
33.5993
iconMarket Capitalization1,597.54M
icon52-Week High40
icon52-Week Low16.78
iconAverage Volume0.94M
iconDividend Yield--
iconP/E Ratio33.5993
What does the Phreesia Inc do?
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients, healthcare provider organizations, and life sciences companies. The company was founded in 2005 and is headquartered in New York, New York.
Read More
How much money does Phreesia Inc make?
News & Events about Phreesia Inc.
Business Wire
2 months ago
Phreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023. Now in its eighth year, the program honors the industrys leaders of tomorrowwomen who...
Zolmax
3 months ago
Phreesia, Inc. (NYSE:PHR Get Rating) SVP Michael J. Davidoff sold 28,555 shares of the businesss stock in a transaction dated Monday, January 30th. The stock was sold at an average price of $36.10, for a total value of $1,030,835.50. Following the completion of the sale, the senior vice president ...
Ticker Report
5 months ago
Phreesia (NYSE:PHR Get Rating) had its target price raised by stock analysts at Robert W. Baird to $41.00 in a report released on Wednesday, Stock Target Advisor reports. Robert W. Bairds target price would indicate a potential upside of 20.55% from the companys current price. ...
Zolmax
1 year ago
New York State Common Retirement Fund raised its holdings in shares of Phreesia, Inc. (NYSE:PHR Get Rating) by 5.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,411 shares of the companys ...
Frequently Asked Questions
Frequently Asked Questions
What is Phreesia Inc share price today?
plus_minus_icon
Can Indians buy Phreesia Inc shares?
plus_minus_icon
How can I buy Phreesia Inc shares from India?
plus_minus_icon
Can Fractional shares of Phreesia Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Phreesia Inc stocks?
plus_minus_icon
What is today’s traded volume of Phreesia Inc?
plus_minus_icon
What is today’s market capitalisation of Phreesia Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Phreesia Inc?
plus_minus_icon
What percentage is Phreesia Inc down from its 52-Week High?
plus_minus_icon
What percentage is Phreesia Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$30.02
$0.2
(0.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$44.90
$1.08 (2.46 %)
APOLLO MEDICAL HOLDINGS INC
APOLLO MEDICAL HOLDINGS INC
$31.62
$0.69 (2.23 %)
agilon health, Inc.
agilon health, Inc.
$19.88
$-0.37 (-1.83 %)
OptimizeRx Corporation
OptimizeRx Corporation
$14.04
$0.34 (2.48 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$44.90
$1.08 (2.46 %)
APOLLO MEDICAL HOLDINGS INC
APOLLO MEDICAL HOLDINGS INC
$31.62
$0.69 (2.23 %)
agilon health, Inc.
agilon health, Inc.
$19.88
$-0.37 (-1.83 %)
OptimizeRx Corporation
OptimizeRx Corporation
$14.04
$0.34 (2.48 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00